Kidder Stephen W - NOVOZYMES A S DKK 2.0 ownership

NOVOZYMES A S DKK 2.0's ticker is and the CUSIP is B798FW902. A total of 8 filers reported holding NOVOZYMES A S DKK 2.0 in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.5%.

Quarter-by-quarter ownership
Kidder Stephen W ownership history of NOVOZYMES A S DKK 2.0
ValueSharesWeighting
Q3 2023$406,592
-13.3%
10,1000.0%0.14%
-8.4%
Q2 2023$469,097
-17.0%
10,100
-9.0%
0.15%
-21.8%
Q1 2023$565,163
+0.8%
11,1000.0%0.20%
-3.9%
Q4 2022$560,524
+0.3%
11,1000.0%0.20%
-10.1%
Q3 2022$559,000
-32.5%
11,100
-19.7%
0.23%
-29.0%
Q2 2022$828,000
-31.9%
13,825
-21.8%
0.32%
-18.1%
Q1 2022$1,215,000
-36.8%
17,674
-24.6%
0.39%
-32.8%
Q4 2021$1,921,000
-25.9%
23,431
-38.2%
0.58%
-28.3%
Q3 2021$2,591,000
-35.4%
37,940
-28.9%
0.81%
-34.3%
Q2 2021$4,011,000
-15.1%
53,330
-27.9%
1.24%
-18.8%
Q1 2021$4,724,000
-0.0%
73,980
-10.4%
1.52%
-3.0%
Q4 2020$4,725,000
-12.9%
82,525
-4.4%
1.57%
-18.3%
Q3 2020$5,425,000
+3.6%
86,358
-4.9%
1.92%
-3.7%
Q2 2020$5,237,000
+25.0%
90,846
-1.2%
2.00%
+4.9%
Q1 2020$4,191,000
-8.8%
91,969
-2.3%
1.90%
+12.5%
Q4 2019$4,595,000
+13.1%
94,143
-2.8%
1.69%
+5.6%
Q3 2019$4,063,000
-8.5%
96,894
+1.5%
1.60%
-10.0%
Q2 2019$4,440,000
+1.2%
95,494
-0.1%
1.78%
-0.1%
Q1 2019$4,386,000
-8.2%
95,611
-10.9%
1.78%
-15.5%
Q4 2018$4,779,000
-20.2%
107,311
-1.9%
2.11%
-3.6%
Q3 2018$5,985,000
+3.8%
109,348
-3.9%
2.19%
-1.1%
Q2 2018$5,765,000
-3.5%
113,800
-1.9%
2.21%
-3.1%
Q1 2018$5,977,000
-11.4%
115,955
-2.1%
2.28%
-5.6%
Q4 2017$6,743,000
+5.1%
118,400
-5.5%
2.42%
+2.3%
Q3 2017$6,414,000
+16.4%
125,231
-0.6%
2.36%
+13.2%
Q2 2017$5,510,000
+11.2%
125,931
+0.7%
2.09%
+9.6%
Q1 2017$4,953,000
+22.4%
124,995
+6.5%
1.90%
+16.2%
Q4 2016$4,048,000
-30.8%
117,415
-11.7%
1.64%
-29.5%
Q3 2016$5,848,000
-6.8%
132,951
+1.9%
2.32%
-6.9%
Q2 2016$6,274,000
+8.5%
130,418
+1.4%
2.50%
+6.5%
Q1 2016$5,782,000
-3.3%
128,618
+3.6%
2.35%
-8.3%
Q4 2015$5,979,000
+24.3%
124,168
+12.4%
2.56%
+6.1%
Q3 2015$4,811,000
-7.5%
110,433
+0.9%
2.41%
+2.6%
Q2 2015$5,202,000
+4.5%
109,433
+0.6%
2.35%
+9.0%
Q1 2015$4,979,000
+11.3%
108,815
+2.7%
2.15%
+11.1%
Q4 2014$4,473,000
-0.6%
105,970
+2.2%
1.94%
-5.2%
Q3 2014$4,501,000
+0.8%
103,720
+16.5%
2.04%
-31.1%
Q2 2014$4,466,000
+6.9%
89,025
-6.3%
2.97%
+5.5%
Q1 2014$4,178,000
+5.0%
95,000
+0.8%
2.81%
+2.7%
Q4 2013$3,979,000
+12.4%
94,275
+1.8%
2.74%
+0.1%
Q3 2013$3,541,000
+20.4%
92,575
+0.8%
2.73%
+15.5%
Q2 2013$2,941,000
+17.4%
91,875
+3.1%
2.37%
+7.6%
Q4 2012$2,506,00089,1252.20%
Other shareholders
NOVOZYMES A S DKK 2.0 shareholders Q4 2020
NameSharesValueWeighting ↓
Delaney Dennis R 32,907$1,897,0002.54%
Fayerweather Charles 22,858$1,318,0002.31%
SOMERVILLE KURT F 206,900$11,927,0002.20%
Gardiner Nancy B 22,350$1,288,0002.13%
Broderick Brian C 106,579$6,143,0002.04%
PUZO MICHAEL J 93,960$5,416,0002.03%
Kidder Stephen W 90,846$5,237,0002.00%
Page Arthur B 37,705$2,173,0001.92%
Dempze Nancy E 26,893$1,549,0001.73%
Hemenway Trust Co LLC 206,922$11,927,0001.66%
View complete list of NOVOZYMES A S DKK 2.0 shareholders